Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Jan;117(2):305–308. doi: 10.1111/j.1476-5381.1996.tb15191.x

Functional characterization of adenosine receptors in the nucleus tractus solitarius mediating hypotensive responses in the rat.

P J White 1, R B Rose'Meyer 1, W Hope 1
PMCID: PMC1909260  PMID: 8789383

Abstract

1. The aim of this study was to characterize adenosine receptors located in the nucleus tractus solitarius (NTS) that mediate decreases in blood pressure in the anaesthetized rat. To determine the adenosine receptor subtype involved, a range of selective agonists and antagonists were studied and their relative potencies evaluated. 2. The rank order of agonist potency in inducing decreases in diastolic blood pressure was N6-cyclopentyladenosine (CPA) > N6-cyclohexyladenosine (CHA) > N-ethyl-carboxamidoadenosine (NECA) > or = 2-phenylaminoadenosine (CV1808) > 2-p-(carboxyethyl)phenethylamino-5' N-ethylcarboxamidoadenosine (CGS 21680) > N6-(2-(4-aminophenyl)ethyl)-adenosine (APNEA). 3. The hypotensive action of CPA following microinjection into the NTS was antagonized by i.v. infusions (50 micrograms kg-1 min-1) of adenosine receptor antagonists, 8-cyclopentyl-1,3 dipropylxanthine (DPCPX), 8-phenyltheophylline (8-PT), 8-(p-sulphophenyl)theophylline (8-SPT), and 1,3-dipropyl-8-N-(2-diethylamino)ethyl)-N methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo) benzenesulphonamidexanthine (PD 115199). The antagonist potency order was DPCPX > PD115199 > or = 8-PT. Intravenous infusion of 8-SPT had no effect on blood pressure responses to microinjection of CPA into the NTS. 4. The results suggest that adenosine A1 receptors in the NTS mediate hypotensive responses in the anaesthetized rat preparation.

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barraco R. A., Phillis J. W. Subtypes of adenosine receptors in the brainstem mediate opposite blood pressure responses. Neuropharmacology. 1991 Apr;30(4):403–407. doi: 10.1016/0028-3908(91)90067-l. [DOI] [PubMed] [Google Scholar]
  2. Bruns R. F., Lu G. H., Pugsley T. A. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol. 1986 Apr;29(4):331–346. [PubMed] [Google Scholar]
  3. Collis M. G., Hourani S. M. Adenosine receptor subtypes. Trends Pharmacol Sci. 1993 Oct;14(10):360–366. doi: 10.1016/0165-6147(93)90094-z. [DOI] [PubMed] [Google Scholar]
  4. Daly J. W., Butts-Lamb P., Padgett W. Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell Mol Neurobiol. 1983 Mar;3(1):69–80. doi: 10.1007/BF00734999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Evoniuk G., von Borstel R. W., Wurtman R. J. Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline. J Pharmacol Exp Ther. 1987 Feb;240(2):428–432. [PubMed] [Google Scholar]
  6. Ferré S., Fuxe K., von Euler G., Johansson B., Fredholm B. B. Adenosine-dopamine interactions in the brain. Neuroscience. 1992 Dec;51(3):501–512. doi: 10.1016/0306-4522(92)90291-9. [DOI] [PubMed] [Google Scholar]
  7. Kamikawa Y., Cline W. H., Jr, Su C. Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats. Eur J Pharmacol. 1980 Sep 5;66(4):347–353. doi: 10.1016/0014-2999(80)90467-7. [DOI] [PubMed] [Google Scholar]
  8. Mathôt R. A., van Schaick E. A., Langemeijer M. W., Soudijn W., Breimer D. D., Ijzerman A. P., Danhof M. Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat. J Pharmacol Exp Ther. 1994 Feb;268(2):616–624. [PubMed] [Google Scholar]
  9. Matias A., Albino-Teixeira A., Polónia J., Azevedo I. Long-term administration of 1,3-dipropyl-8-sulfophenylxanthine causes arterial hypertension. Eur J Pharmacol. 1991 Jan 25;193(1):101–104. doi: 10.1016/0014-2999(91)90206-6. [DOI] [PubMed] [Google Scholar]
  10. Mosqueda-Garcia R., Tseng C. J., Appalsamy M., Beck C., Robertson D. Cardiovascular excitatory effects of adenosine in the nucleus of the solitary tract. Hypertension. 1991 Oct;18(4):494–502. doi: 10.1161/01.hyp.18.4.494. [DOI] [PubMed] [Google Scholar]
  11. Rabkin S. W. D-Ala-2-Me-Phe-4-Met-(O)-ol-enkephalin in the nucleus tractus solitarius of the rat produces cardiorespiratory depression. Gen Pharmacol. 1991;22(3):479–484. doi: 10.1016/0306-3623(91)90009-u. [DOI] [PubMed] [Google Scholar]
  12. St Lambert J. H., Dawid-Milner M. S., Silva-Carvalho L., Spyer K. M. Action of adenosine receptor antagonists on the cardiovascular response to defence area stimulation in the rat. Br J Pharmacol. 1994 Sep;113(1):159–164. doi: 10.1111/j.1476-5381.1994.tb16188.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Talman W. T., Lewis S. J. Altered cardiovascular responses to glutamate and acetylcholine microinjected into the nucleus tractus solitarii of the SHR. Clin Exp Hypertens A. 1991;13(5):661–668. doi: 10.3109/10641969109042069. [DOI] [PubMed] [Google Scholar]
  14. Tao S., Abdel-Rahman A. A. Neuronal and cardiovascular responses to adenosine microinjection into the nucleus tractus solitarius. Brain Res Bull. 1993;32(4):407–417. doi: 10.1016/0361-9230(93)90208-s. [DOI] [PubMed] [Google Scholar]
  15. Williams M. Adenosine antagonists. Med Res Rev. 1989 Apr-Jun;9(2):219–243. doi: 10.1002/med.2610090205. [DOI] [PubMed] [Google Scholar]
  16. Zhou Q. Y., Li C., Olah M. E., Johnson R. A., Stiles G. L., Civelli O. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7432–7436. doi: 10.1073/pnas.89.16.7432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. van Calker D., Müller M., Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979 Nov;33(5):999–1005. doi: 10.1111/j.1471-4159.1979.tb05236.x. [DOI] [PubMed] [Google Scholar]
  18. von Kügelgen I., Späth L., Starke K. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex. Br J Pharmacol. 1994 Nov;113(3):815–822. doi: 10.1111/j.1476-5381.1994.tb17066.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES